Aqua Bio Technology ASAOSTO:ABTO 29 Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus rates OSTO:ABTO with a GF Score™ of 29/100 and a GF Value™ of kr3.37 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,205 Biotechnology companies, Aqua Bio Technology ASA ranks worse than 82987.47% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aqua Bio Technology ASA's annualized net income for the quarter that ended in Dec. 2025 was kr-21.90 Mil. Aqua Bio Technology ASA's average shareholder tangible equity for the quarter that ended in Dec. 2025 was kr-0.08 Mil. Therefore, Aqua Bio Technology ASA's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was N/A%.
The historical rank and industry rank for Aqua Bio Technology ASA's Return-on-Tangible-Equity or its related term are showing as below:
During the past 13 years, Aqua Bio Technology ASA's highest Return-on-Tangible-Equity was 2.31%. The lowest was -697.81%. And the median was -302.49%.
OSTO:ABTO's Return-on-Tangible-Equity is not ranked *
in the Biotechnology industry.
Industry Median: -42.47 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
Aqua Bio Technology ASA (OSTO:ABTO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aqua Bio Technology ASA Return-on-Tangible-Equity Related Terms
Aqua Bio Technology ASA Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Aqua Bio Technology ASA's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aqua Bio Technology ASA Return-on-Tangible-Equity Chart
OSTO:ABTO vs VRTX, REGN, ALNY: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Aqua Bio Technology ASA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aqua Bio Technology ASA Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aqua Bio Technology ASA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Aqua Bio Technology ASA (OSTO:ABTO) has a Return-on-Tangible-Equity of 0.00% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aqua Bio Technology ASA and its competitors. According to the industry distribution chart, Aqua Bio Technology ASA ranks #999999 out of 1205 companies in the Biotechnology industry.
Is Aqua Bio Technology ASA's Return-on-Tangible-Equity too high?
Aqua Bio Technology ASA's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Aqua Bio Technology ASA ranks #999999 out of 1205 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aqua Bio Technology ASA has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's Return-on-Tangible-Equity compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aqua Bio Technology ASA ranks #999999 out of 1205 companies for Return-on-Tangible-Equity. This places Aqua Bio Technology ASA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aqua Bio Technology ASA and its competitors. Aqua Bio Technology ASA's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Based on GuruFocus' analysis, Aqua Bio Technology ASA (OSTO:ABTO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr3.37, compared to a current price of kr6.82 — trading 102.4% above its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Aqua Bio Technology ASA's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aqua Bio Technology ASA (OSTO:ABTO), the current Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aqua Bio Technology ASA (OSTO:ABTO) Overvalued in 2026?
Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued.
The current stock price of kr6.82 is trading 102.4% above its estimated GF Value™ of kr3.37.
GuruFocus considers Aqua Bio Technology ASA to be Significantly Overvalued.
Key valuation signals for OSTO:ABTO:
Return-on-Tangible-Equity: 0.00%
GF Value™: kr3.37 vs. price of kr6.82 (102.4% above fair value)
No single metric tells the full story. See the OSTO:ABTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
29GF Score
Get the complete analysis for OSTO:ABTO
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ABTO has been successfully added to your 
